Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 1 4

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4Sarcoma 1Genitourinary 1Breast 1

Conditions

Leukemia, Myeloid, Acute 63Myelodysplastic Syndromes 27Leukemia 13Leukemia, Myelomonocytic, Chronic 12Congenital Abnormalities 9Recurrence 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Primary Myelofibrosis 6Thrombocythemia, Essential 4Polycythemia Vera 4Neoplasms 4Melanoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Burkitt Lymphoma 3Blast Crisis 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

pembrolizumab 92Nivolumab 56Ipilimumab 55Cyclophosphamide 52Vemurafenib 28fludarabine 27aldesleukin 25Interleukin-2 25fludarabine phosphate 21trametinib 20dabrafenib 17Temozolomide 14Biopsy 14Cisplatin 13spartalizumab 12atezolizumab 12Carboplatin 11cobimetinib 10Specimen Handling 10Paclitaxel 10Introns 10CTLA-4 Antigen 10poly ICLC 9binimetinib 9Radiotherapy 9Radiosurgery 9MART-1 Antigen 9tremelimumab 8incomplete Freund's adjuvant 8Radiation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Melanoma × Decitabine × Clear all
NCT00791271 2018-11-09

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

M.D. Anderson Cancer Center

Phase 1 Terminated
17 enrolled
Dermatologic

Melanoma

NCT01876641 2018-09-19

ML28604

University of Iowa

Phase 1 Terminated
18 enrolled
Dermatologic

Melanoma

NCT02839694 2018-07-05

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

NCT00030615 2013-02-07

Decitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
BreastDermatologicGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Melanoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡